get a key
steadybase-$ company NBIX
account_id none on file
legal_name Neurocrine Biosciences Inc
ticker NBIX
cik 914475
domain neurocrine.com
entry_point_account_id none on file
name Neurocrine Biosciences Inc.
exchange Nasdaq
sector Health Care
hq San Diego, CA, United States
calls 0 filings 53 executives 0 family 0
why_nownone on file
callsnone on file
filings
In addition, the unaudited pro forma financial information is not a projection of future results of operations of the combined company nor does it reflect the expected realization of any synergies or cost savings associated with the acquisition.

filing / Jul 31, 2026 / receipt

Additionally, recent policy discussions have included potential targeted tariffs or other trade measures specifically aimed at pharmaceutical products and ingredients as part of broader healthcare cost control or national security initiatives.

filing / Jul 31, 2026 / receipt

Our operating leases that have commenced have terms that expire beginning 2027 through 2036 and consist of office space and research and development laboratories, including our corporate headquarters.

filing / Jul 31, 2026 / receipt

Our operating leases that have commenced have terms that expire beginning 2027 through 2036 and consist of office space and research and development laboratories, including our corporate headquarters.

filing / May 5, 2026 / receipt

The implementation of these cost containment measures may prevent us from being able to generate revenue, attain sustained profitability or commercialize our drugs, particularly since the majority of our current revenue is derived from federal healthcare programs, including Medicare and Medicaid.

filing / May 5, 2026 / receipt

Additionally, recent policy discussions have included potential targeted tariffs or other trade measures specifically aimed at pharmaceutical products and ingredients as part of broader healthcare cost control or national security initiatives.

filing / May 5, 2026 / receipt

Associate Director, Clinical Supply Chain | {"ats": "workday", "city": null, "state": null, "job_id": "/job/US-CA-San-Diego/Associate-Director--Clinical-Supply-Chain_R7247", "remote": false, "category

company_statement / Sep 15, 2026 / receipt

Sr. Specialist, Space Planning | {"ats": "workday", "city": null, "state": null, "job_id": "/job/US-CA-San-Diego/Sr-Specialist--Space-Planning_R7251-1", "remote": false, "category": "other", "function

company_statement / Sep 15, 2026 / receipt

Sr. Specialist, QA Operations | {"ats": "workday", "city": null, "state": null, "job_id": "/job/US-CA-San-Diego/Sr-Specialist-CQA_R7239", "remote": false, "category": "other", "function": "engineering

company_statement / Sep 15, 2026 / receipt

Federal Government Affairs Manager | {"ats": "workday", "city": null, "state": null, "job_id": "/job/US-DC-Office/Federal-Government-Affairs-Manager_R7245-1", "remote": false, "category": "other", "fu

company_statement / Sep 15, 2026 / receipt

2026 INGREZZA Net Sales and Expense Guidance Reaffirmed

ir_statement / Sep 15, 2026 / receipt

SG&A guidance range reflects expense for ongoing commercial initiatives supporting INGREZZA growth and the launch of CRENESSITY including expansion of sales teams.

ir_statement / Sep 15, 2026 / receipt

executivesnone on file
familynone on file
upcoming
2026-10-27 earnings call scheduled webcast / ir
changesnone on file
mcp_package_hint
steadybase-$